Clinical trial

Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy

NCT07357948

Study summary

ClinicalTrials.gov

Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapy

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

PROCEDURE · Unmapped registry intervention Omission of surgery Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-08-01

PhaseNA

Conditions

Triple Negative Breast Cancerunresolved

Non-Metastaticunresolved

Interventions

Omission of surgeryPROCEDURE

Sponsors & collaborators

Institut Curielead sponsor

Mapped research locations

ParisFrance2 DijonFrance1 Saint-CloudFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07357948 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.